drugset / Trial / NCT01728753
T-705a Multicenter Study in Adults Subjects With Uncomplicated Influenza
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is safety and pharmacokinetics (PK) of favipiravir study in adults 18-80 years of age diagnosed with uncomplicated influenza.
Timeline
- Start
- 2012-11
- Primary completion
- 2013-02
- Completion
- 2013-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Favipiravir | Small molecule | 600 mg | Oral |
| Subject | Favipiravir | Small molecule | 800 mg | Oral |